Nuclear Magnetic Resonance for Embryo Ploidy Selection

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-04-07

Study Completion Date

2023-12-06

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to validate the embryo culture medium analysis by nuclear magnetic resonance spectroscopy, as a faster and less-costly alternative to preimplantation genetic test for aneuploidy which could significantly enhance embryo selection and the success rate of assisted reproductive technologies.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Identification of Viable Human Embryos Using Three Different Methods

NCT01139268

Infertility

COMPLETED

Embryo Selection by Noninvasive Preimplantation Genetic Test

NCT04339166

Infertility Chromosome Abnormality

COMPLETED NA

Noninvasive Chromosomal Screening for Embryo Selection Trial

NCT04732013

Infertility Aneuploidy

UNKNOWN

Predictive Value of Embryonic Testing

NCT03604107

Infertility

COMPLETED

RCT Study to Validate niPGT-A Clinical Benefit.

NCT04000152

Aneuploidy Chromosome Abnormality Infertility

TERMINATED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Assisted reproductive technologies (ART) refers to treatments used to assist people in achieving a pregnancy. Over the last years, ART have been developed with efforts to deliver a healthy baby. However, the selection of the embryo that most likely results in pregnancy remains a critical step in ART. Currently, this selection is based on morphological assessment of the embryos, but up to 70% of those embryos display an abnormal number of chromosomes. Preimplantation genetic test for aneuploidy (PGT-A) is used to assess the ploidy of embryos, although this is an invasive, expensive and time consuming technique. Alternatively, in order to predict the ploidy of pre-implantation embryos (euploidy vs aneuploidy), we suggest to characterise the metabolic profile of the embryo culture medium by Nuclear Magnetic Resonance (NMR), which is a non-invasive, low cost and fast technique.

The aim of this study is to assess whether, using multivariable analysis to all the collected NMR data, it is possible to identify a differential metabolic pattern between aneuploid and euploid embryos which could improve embryo selection.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Aneuploidy Infertility

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Nuclear magnetic resonance analysis of embryo culture medium

Analysis of culture medium from euploid and aneuploid embryos by magnetic nuclear resonance.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age: ≥18 and \<49 years old.
* Body Mass Index ≥18.5 Kg/m2 and \<30 Kg/m2.
* Planned for in vitro fertilization followed by preimplantation genetic test for aneuploidy.
* Oocytes retrieval and fertilization by intracytoplasmic sperm injection
* Six follicles over 14 mm on the day of the triggering. Gonadotropin-releasing hormone antagonist
* Signed and dated informed consent.

Exclusion Criteria

* Previous history of poor ovarian response (\<4 oocytes retrieved) with a maximal dose of ovarian stimulation (≥300 IU/day).
* Presence of a medical condition which is known to affect assisted reproductive technologies outcome (e.g. thyroid dysfunction).
* Active female smoking.
* Current use of anti-depressants, anti-psychotics, steroids, antiepileptics or chemotherapy.
* Those unable to comprehend the investigational nature of the proposed study.

Minimum Eligible Age

18 Years

Maximum Eligible Age

48 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes